Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCT1050220063
JPRN-jRCT1050220063
Recruiting
Phase 1

Efficacy and safety of hemodilutional autologous blood transfusion for intermediate- to advanced- liver resection

chida Yoichiro0 sites50 target enrollmentJuly 14, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAll disease which would be required for hepatectomyhepatectomy, hemodilutionalautologous blood transfusion (HAT)

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
All disease which would be required for hepatectomy
Sponsor
chida Yoichiro
Enrollment
50
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 14, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
chida Yoichiro

Eligibility Criteria

Inclusion Criteria

  • •1\. More than 18 years
  • •2\. All disease which would be required for hepatectomy
  • •3\. intermediate\-to\-difficult hepatectomy
  • •4\. HAT cases

Exclusion Criteria

  • •1\. Hepatectomy with concomitant some surgery (e.g., gastrectomy or pancreaticoduodenecrtomy)
  • •2\. Donor hepatectomy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
Autologous Haematopoietic Stem Cell Transplantation for highly active treatment resistant multiple sclerosis.
ACTRN12619000348156Alfred Health50
Recruiting
Not Applicable
Evaluation of efficacy and safety of autologous bone marrow mesenchymal stem cells for traumatic spinal cord injury: Use-results comparative survey
JPRN-jRCT2053210130Room Stemirac Information612
Recruiting
Phase 1
The safety and efficacy of autologous peripheral blood mononuclear cell ex vivo culture amplified cells (MNC-QQ) for alopecia: Phase 1 / 2 clinical study
JPRN-jRCTb030230286Ikeda Yoshio5
Not yet recruiting
Phase 1
Safety and clinical effectiveness of autologous mesenchymal stromal cell infusion as adjuncttreatment in patients with Idiopathic Pulmonary FibrosisJ84.1Other interstitial pulmonary diseases with fibrosis
DRKS00008790The Republican Research and Practical Centre for Pulmonology and TB40
Completed
Not Applicable
Efficacy and Safety Profile of Autologous Blood Versus Talc Pleurodesis for Malignant Pleural EffusioSymptomatic malignant pleural effusion patientsPleurodesis&#44Autologous blood&#44Talc&#44Malignant pleural effusion&#44MPE&#44Efficacy
TCTR20150717001Human Research Ethic Committee108